Biomerieux 69 Marcy L'Etoile/  FR0013280286  /

Nasdaq Other OTC
2024-05-16  5:06:56 PM Chg. - Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
101.9100USD - 60
Turnover: 6,114.6000
-Bid Size: - -Ask Size: - 12.31 bill.USD - -

Fundamentals

  FY 2023 Growth (1Y)
Per Share  
Earnings per Share: 3.03 EUR -21.09%
EPS Diluted: - EUR -21.20%
Revenues per Share: 31.05 EUR 2.39%
Book Value per Share: 31.70 EUR 3.00%
Cash Flow per Share: 3.76 EUR -6.25%
Dividend per Share: 0.85 EUR 0.00%
Total in mill.  
Revenues: 3,674.70 EUR 2.39%
Net Income: 357.60 EUR -20.95%
Operating Cash Flow: 445.40 EUR -
Cash and Cash Equivalents: 352.40 EUR -

Valuation Ratios

  Current Latest FY*
P/E Ratio: 31.65 33.20
P/S Ratio: 3.09 3.24
P/BV ratio: 3.03 3.17
P/CF Ratio: 25.48 26.73
PEG: -1.50 -1.57
Earnings Yield: 3.16% 3.01%
Dividend Yield: 0.89% 0.84%
Market Capitalization  
Market Capitalization: 12.31 bill. USD 13.16 bill. USD
Free Float Market Cap.: - USD - USD
Market Cap. / Employee: - USD - USD
Shares Outstanding: 118.36 mill.  
 

Profitability

Gross Profit Margin: 55.99%
EBIT Margin: 11.95%
Net Profit Margin: 9.73%
Return on Equity: 9.53%
Return on Assets: 6.80%

Financial Strength

Liquidity I / Cash Ratio: 32.41%
Liquidity II / Quick Ratio: 99.42%
Liquidity III / Current Ratio: 202.81%
Debt / Equity Ratio: 40.16%
Dynam. Debt / Equity Ratio: 338.35%

Efficiency

Employees: -
Personal Expenses / Employee: - EUR
Revenues / Employee: - EUR
Net Income / Employee: - EUR
Total Assets / Employee: - EUR
 
* Fiscal Year End: 2023-12-31
Accounting Standard: IFRS
Currency: EUR